Imvax logo

Imvax

Philadelphia, PA

Imvax is a clinical-stage biotechnology company with a unique immunotherapy approach to solid tumors.

imvax.com

Company Details

Founded

2015

Employees

Between 20 - 100 employees

Raised

$253,694,656

Headquarters Location

Philadelphia, PA

Public

No

Acquired

No

CEO

John FureyJohn Furey

Founders

Peter B. Corr
Peter B. Corr
Art Howe
Art Howe
David Andrews
David Andrews
D. Craig Hooper

Company Collections

These are collections Imvax is a part of. Click on the collection name to view similar companies.

Imvax's Industries

Imvax's Tech Stack

Imvax Headquarters Location

601 Walnut Street Suite 440, Philadelphia, PA 19106

Total Amount Raised: $253,694,656

Imvax Funding Rounds

  • Series Unknown

    $29,000,000

  • Series Unknown

    $35,000,000

  • Series Unknown

    $23,000,000

  • Series C

    $112,000,000

    Series C Investors

    HP WILD HOLDING
    TLP Invest
    Ziff Capital Partners
    Invus
    Magnetar Capital

  • Series B

    $40,000,000

    Series B Investors

    Ziff Capital Partners
    Magnetar Capital
    WILD Group Management

  • Series A

    $14,694,660

Funding info provided by Diffbot.

Imvax Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Imvax.

Recent reviews